Lecture abstract: Turbo cancers are a rapidly escalating threat in the wake of the COVID pandemic, forcing doctors to push the boundaries of traditional oncology treatment. This presentation, with Dr. Kathleen Ruddy, Dr. Paul Marik, and Dr. Nathan Goodyear, introduces groundbreaking adjunctive treatment strategies that are reshaping cancer care. Highlighting the role of repurposed drugs like ivermectin, alongside metabolic therapy and lifestyle modifications, the speakers present a more personalized and less invasive approach to cancer treatment. Join us to discover the future of oncology, where innovation meets practicality.